Does starting naltrexone in a patient with alcohol use disorder and elevated baseline liver transaminases cause further liver injury compared with acamprosate and gabapentin?doi:10.1097/EBP.0000000000001963André BiscayeWilliam E. MichaelWolters KluwerEvidence-Based Practice...
study on major depressive disorder where the authors randomized 12 patients to naltrexone 1 mg/day or placebo, there were borderline significant improvements in some clinical depression measures4. These results are part of the documentation in a patent application on the use of LDN in depression ...